Does lamotrigine influence valproate concentrations?

Therapeutic Drug Monitoring

Volumn 24, Issue 5, 2002, Pages 631-636

  Mataringa, Mihaela Irina ^a   May, Theodor W ^a   Rambeck, Bernhard ^a  

^a Biochemisches Labor   (Germany)

Author keywords

Drug interactions; LTG; VPA

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; MESUXIMIDE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; BODY WEIGHT; CHILD; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; EPILEPSY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; DRUG INTERACTIONS; EPILEPSY; FEMALE; HUMANS; MALE; REGRESSION ANALYSIS; TRIAZINES; VALPROIC ACID;

EID: 0036786119     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200210000-00009     Document Type: Article

References (22)

1. Sackellares JC, Sato S, Dreifuss FE, et al. Reduction of steady-state valproate levels by other antiepileptic drugs. Epilepsia 1981; 22:437-441.
2. Henriksen O, Johannessen SI. Clinical and pharmacokinetic observations on sodium valproate-a 5-years follow-up study in 100 children with epilepsy. Acta Neurol Scand 1982;65:504-523.
3. Mesdjian E, Dravet C, Roger J. Sodium valproate plasma levels (total level and free fraction level) in epileptic patients: influence of dose, age, and associated therapy. In: Levy RH, Pitlick WH, Eichelbaum M, et al. eds. Metabolism of antiepileptic drugs. New York: Raven Press, 1984:115-125.
4. Scheyer RD, Mattson RH. Valproate-interactions with other drugs. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. New York: Raven Press, 1995:621-631
5. May T, Rambeck B. Serum concentrations of valproic acid: influence of dose and comedication. Ther Drug Monit 1985;7:387-390.
6. Brodie MJ, Yuen AWC, 105 Study Group. Lamotrigine substitution study: evidence for synergism with sodium valproate? Epilepsy Res 1997;26:423-432.
7. Pisani F, Oteri G, Russo MF, et al. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 1999;40: 1141-1146
8. Rambeck B, Wolf P. Lamotrigine clinical Pharmacokinetics, Clin Pharmacokinet 1993;25:433-443.
9. May TW, Rambeck B, Jürgens U. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication. Ther Drug Monit 1996;18:523-531.
10. Rambeck B, Specht U, Wolf P. Pharmacokinetic Interaction of the New Antiepileptic Drugs. Clin Pharmacokinet 1996;31:309-324.
11. Anderson GD, Yau MK, Gidal BE, et al. Bidirectional interaction of valproate and lamotrigine in healthy subjects. Clin Pharmacol Ther 1996:60:145-156.
12. Eriksson AS, Hoppu K, Nergardh A, et al. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. Epilepsia 1996;37:769-773.
13. Dijkhuis I, Vervloet E: Rapid determination of the antiepileptic drug di-n-propylacetic acid in serum. Pharmaceutisch Weekblad 1974;109:42-45.
14. Juergens U. HPLC analysis of antiepileptic drugs in blood samples: microbore separation of fourteen compounds. J Liquid Chromatogr 1987;10:507-532.
15. Jawad S, Yuen WC, Peck AW et al Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy. Epilepsy Res 1987;1:194-201.
16. Sander J, Patsalos PN, Oxley JR, et al. A randomized double-blind controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 1990;6:221-226.
17. Besag FMC, Berry DJ, Vasey M. Methsuximide reduces valproic acid serum levels. Ther Drug Monit 2001;23:694-697.
18. Sälke-Kellermann A, May TW, Boenigk HE. Influence of ethosuximide on valproic acid serum concentrations. Epilepsy Res 1997;26:345-349.
19. Cloyd JC, Fischer JH, Kriel RL, et al. Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance. Clin Pharmacol Ther 1993; 53:22-29.
20. Frey M, Kanner AM. Do lamotrigine and valproic acid have an additive anticonvulsant effect? Epilepsia 1999;40 (Suppl 7):144.
21. Reutens DC, Duncan JS, Patsalos PN. Disabling tremor after lamotrigine with sodium valproate. Lancet 1993;342:185-186.
22. Panayiotopoulos CP, Ferrie CD, Knott C, et al. Interaction of lamotrigine with sodium valproate. Lancet 1993;341:445.